Clinical Trial Update: Topical ENS-002 for Atopic Dermatitis in Adults [Phase 1]

View source ↗

Summary

Concerto Biosciences reports termination of its Phase 1 trial of topical ENS-002 for adults with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ENS-002 (ENS-002)

Snippet

Sponsor: Concerto Biosciences | Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Status: TERMINATED